“Prdx5 Inhibition Suppresses Drug-Tolerant Prostate Cancer Cell Proliferation and Stabilizes Disease Progression in Patients”

https://pubmed.ncbi.nlm.nih.gov/38115765

The study identifies PRDX5 as a potential target for treating castration-resistant prostate cancer, as its inhibition suppresses drug-tolerant cell proliferation and stabilizes disease progression in patients.